Quick Answer
REGENEREX PHARMA, INC. reported Gross Profit of -$244.9 thousand for fiscal year 2021.
REGENEREX PHARMA, INC. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2021 | -$244.9K | -27434.5% |
| 2020 | $896.00 | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| December 31, 2020 | -$183.00 | -112.4% | -312.8% |
| September 30, 2020 | $86.00 | — | +24.6% |
| June 30, 2020 | $69.00 | — | -95.3% |
| December 31, 2019 | $1.5K | — | — |
- REGENEREX PHARMA, INC. showed a decrease of -27434.5% in Gross Profit compared to the prior fiscal year.
- Over the 2020–2021 period, REGENEREX PHARMA, INC.’s gross profit has declined by 27434.5% (from $896.00 to -$244.9 thousand).
- The most recent figure is from REGENEREX PHARMA, INC.’s fiscal year 2020 report (Form 10-K), filed with the SEC on June 23, 2021.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: